BlackRock Advisors’s Kyntra Bio KYNB Stock Holding History

BlackRock Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.69M	Sell	5,024 -178	-3%	-$88.9K	﹤0.01%	1381
2016 Q3	$2.69M	Sell	5,202 -214	-4%	-$101K	﹤0.01%	1359
2016 Q2	$2.22M	Buy	5,416 +1,733	+47%	+$794K	﹤0.01%	1391
2016 Q1	$1.96M	Sell	3,683 -115	-3%	-$57.3K	﹤0.01%	1430
2015 Q4	$2.89M	Sell	3,798 -1,286	-25%	-$853K	﹤0.01%	1273
2015 Q3	$2.79M	Sell	5,084 -271	-5%	-$164K	﹤0.01%	1264
2015 Q2	$3.15M	Buy	5,355 +4,514	+537%	+$2.63M	﹤0.01%	1116
2015 Q1	$659K	Sell	841 -55	-6%	-$42.6K	﹤0.01%	1870
2014 Q4	$613K	Buy	+896	New	+$577K	﹤0.01%	1848

Other funds holding KYNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

BlackRock Advisors's KYNB Position: Q4 2016 in Review

BlackRock Advisors reduced its Kyntra Bio (KYNB) stake by 3.4% in Q4 2016, selling an estimated $88.9K and leaving 5,024 shares worth $2.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1381.

BlackRock Advisors first reported a position in KYNB in Q4 2014 and has held it in 9 quarters since. The position peaked at $3.15M in Q2 2015. 140 funds tracked by Wall St. Rank hold KYNB as of Q4 2016.

BlackRock Advisors held 5,024 shares of Kyntra Bio worth $2.69M as of Q4 2016.
BlackRock Advisors sold 178 Kyntra Bio shares in Q4 2016, an estimated $88.9K.
Kyntra Bio made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1381 holding.
BlackRock Advisors first reported a position in Kyntra Bio in Q4 2014 and has held it in 9 quarters since.
BlackRock Advisors's Kyntra Bio position peaked at $3.15M in Q2 2015.
140 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.